Mervyn Turner

Mervyn Turner

Chairman at
Lunac Therapeutics Ltd.
79 year
Health Technology
Finance
Technology Services

Profile

Mervyn J.
Turner
is the founder of PrescribeWell, Inc. Current jobs include Chairman at Lunac Therapeutics Ltd., Director at PharmAkea, Inc., Director at EnGeneIC Pty Ltd., Director at Spinogenix, Inc., Director at Amydis, Inc., Director at SAB Sciences, Inc. since 2020, and Board of Strategic Advisor at Excel Medical Ventures LLC.
Former jobs include Director at Preventice Technologies, Inc., Director at Tunitas Therapeutics, Inc., Independent Director at Big Cypress Acquisition Corp., Independent Director at SAB Biotherapeutics, Inc., Independent Director at Adagene, Inc. from 2023 to 2025, Chief Strategy Officer & Senior Vice President at Merck & Co., Inc. in 2011, Chief Strategy Officer at Schering-Plough Corp.
in 2009, Advisor at Quaker Partners Management LP, and Chief Strategy Officer & SVP-Worldwide Licensing at Merck Sharp & Dohme Corp.
from 1999 to 2009.
Education includes a doctorate from The University of Sheffield.

Mervyn Turner active positions

CompaniesPositionStart
Consultant / Advisor -
Director/Board Member -
Director/Board Member -
Director/Board Member 2020-12-15
Chairman -
Director/Board Member -
Director/Board Member -

Former positions of Mervyn Turner

CompaniesPositionEnd
ADAGENE INC. Director/Board Member 2025-03-23
MERCK & CO., INC. Corporate Officer/Principal 2011-10-02
░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░░ ░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Mervyn Turner's experience

Training of Mervyn Turner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

77

1st degree connections

18

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies18

Health Technology

Health Technology

Technology Services

Health Technology

Finance

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Health Technology

Finance

Health Technology

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!